In a statement announcing the news, Edwards said it “considers this agreement a positive development."

Cardiology has seen its revenue and utilization take significant hits as a result of the COVID-19 pandemic.

The report comes as confirmed cases continue to rise in certain parts of the country. If that surge continues, the pandemic's financial impact “could be even more significant.”

An antibody currently being developed by Corvidia, ziltivekimab, is at the center of the big acquisition.

The U.S. Preventive Services Task Force has reaffirmed its recommendation that all adults undergo hypertension screening, calling it “a major contributing risk factor to heart failure, heart attack, stroke and chronic kidney disease.”

Back in April, Attebery announced his resignation from the ACC and MedAxiom.

Experts agree that cardiology programs can help address the specialty's diversity problem—but what steps can be taken to make a real difference?  

Endologix, an Irvine, California-based healthcare company focused on aortic disorders, has filed for Chapter 11 bankruptcy and finalized a “consensual plan of reorganization."

Foldax, a Salt Lake City-based healthcare company focused on heart valve technology, has closed a $20 million Series D round of financing.